GL1X · GenesisL1 explorer

MolNFT v1 · #159611 · protein

Crystal structure of TYK2 with novel pyrrolidinone inhibitor

6OVA · Non-receptor tyrosine-protein kinase TYK2: “Crystal structure of TYK2 with novel pyrrolidinone inhibitor”. X-ray diffraction, 1 ligand (N9G), 4 pockets (best druggability 0.67). MolNFT v1 #159611 on GenesisL1: 3D structure, binding…

PDB
6OVA
Type
protein
Length
273 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Non-receptor tyrosine-protein kinase TYK2
EC
2.7.10.2
UniProt
P29597
Ligands
N9G
Pockets
4 · best druggability 0.67

Structure

x-ray diffraction · 1 distinct chain · 41% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANon-receptor tyrosine-protein kinase TYK2 (EC 2.7.10.2)protein27341% helix, 21% strandP29597

Ligands and binding sites

  • N9G · 6-({4-[(3S)-3-cyano-3-cyclopropyl-2-oxopyrrolidin-1-yl]pyridin-2-yl}amino)-N,N-dimethylpyridine-3-carboxamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11890.670.8630N9G
2930.440.7916empty
3920.370.7624empty
4590.280.7316empty

Compared structures

  • 6OVA · Crystal Structure of TYK2 with novel pyrrolidi inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.